Promotion of Early Detection of Lung Cancer in Primary Care by Kowalski Frank, Lesleigh
Promotion of Early Detection of Lung Cancer in Primary Care
Lesleigh Kowalski Frank, MOT, OTR/L, ATP
PhD Student
College of Health Professions | Pacific University | Hillsboro | Oregon
INTRODUCTION
Lung cancer has the highest mortality rate of any 
cancer in the United States, and is increasing in 
developed countries throughout the world. Lung 
cancer is typically diagnosed at stage III or IV due 
to presentation of non-specific symptoms and a 
lack of awareness by patients and providers 
alike. However, diagnosis at stage I or II 
significantly increases one’s survival rate. 
Screening for lung cancer is difficult with tests 
that are expensive, potentially harmful, or 
ineffective.
Overarching research question: How can lung 
cancer be detected earlier in primary care 
settings?
STUDY ONE: QUALITATIVE
STUDY TWO: QUANTITATIVE
Purpose: Examine and identify barriers to 
recommending low dose computed tomography 
lung cancer screenings in order to promote 
screening in rural and/or underserved 
populations.
Research questions: 
• What are the perceived barriers of primary 
care providers practicing in Alaska to 
diagnosing patients with lung cancer? 
• What are the perceived barriers to LDCT 
screening?
• What is the utilization of LDCT screening in 
Alaska after the USPSTF guideline was 
published?
Procedures:
• Data from American Cancer Society/State of 
Alaska
• Regression discontinuity design
• Analyze difference in LDCT lung cancer 
screening performed prior to 
recommendation in 2013 compared to after 
recommendation
• Follow-up with survey to primary care 
providers in Alaska to assess/identify their 
perceptions of barriers to lung cancer 
diagnostics 
STUDY THREE: QUANTITATIVE
Purpose: Determine if tracking certain 
biomarkers, such as weight and hemoglobin 
levels, provides the opportunity to investigate ill-
health earlier.
Research questions: 
• Is there an observable pattern of hemoglobin 
decline in people prior to receipt of a lung 
cancer diagnosis?
• Does monitoring weight provide an 
opportunity to diagnose lung cancer earlier?
Procedures:
• Utilize opportunity to partner with University 
of Washington to analyze biological data of 
people with known lung cancer
• Create locally weighted scatterplot
THEORY AND FRAMEWORK
LITERATURE CITED
CONTACT INFORMATION
Philosophical foundation: 
• Constructivism
Theories applied to research:
• Health Belief Model
• Occupational Therapy Practice Framework
• Andersen Model of Total Patient Delay
• Biopsychosocial Model
Assumptions:
• People construct their own reality
• Less engagement in physical inactivity may be 
a sign of lung cancer
• Each aspect within a person’s biopsychosocial 
existence may promote or prevent the early 
detection of lung cancer
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Purpose: Explore critical influences in the 
delayed diagnosis of lung cancer
Research questions: 
• What is the process a person undergoes from 
recognition of an initial change in health to 
receipt of a diagnosis of lung cancer?
• What are the characteristics of participants’ 
functional presentation prior to receiving a 
diagnosis of lung cancer? 
• What factors contribute to a delayed lung 
cancer diagnosis?
Case study design
• Holistic approach
• Interview people diagnosed with stage III/IV 
lung cancer
• Examine medical records
• Interview family members
• Photographs
• Goal is to map trajectory of events through 
functional decline
• Data coding: Depression, neuropathy, self-
medication, participation in basic activities of 
daily living, and participation in instrumental 
activities of daily living
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